156 related articles for article (PubMed ID: 32919086)
21. Relationship Between Etonogestrel Concentrations and Bleeding Patterns in Contraceptive Implant Users.
Lazorwitz A; Aquilante CL; Dindinger E; Harrison M; Sheeder J; Teal S
Obstet Gynecol; 2019 Oct; 134(4):807-813. PubMed ID: 31503152
[TBL] [Abstract][Full Text] [Related]
22. Prolonged use of the etonogestrel implant and levonorgestrel intrauterine device: 2 years beyond Food and Drug Administration-approved duration.
McNicholas C; Swor E; Wan L; Peipert JF
Am J Obstet Gynecol; 2017 Jun; 216(6):586.e1-586.e6. PubMed ID: 28147241
[TBL] [Abstract][Full Text] [Related]
23. Six- and twelve-month documented removal rates among women electing postpartum inpatient compared to delayed or interval contraceptive implant insertions after Medicaid payment reform.
Crockett AH; Pickell LB; Heberlein EC; Billings DL; Mills B
Contraception; 2017 Jan; 95(1):71-76. PubMed ID: 27400823
[TBL] [Abstract][Full Text] [Related]
24. Long-term depot medroxyprogesterone acetate (Depo-Provera) use in inner-city adolescents.
Polaneczky M; Liblanc M
J Adolesc Health; 1998 Aug; 23(2):81-8. PubMed ID: 9714170
[TBL] [Abstract][Full Text] [Related]
25. Complications and continuation rates associated with 2 types of long-acting contraception.
Berenson AB; Tan A; Hirth JM
Am J Obstet Gynecol; 2015 Jun; 212(6):761.e1-8. PubMed ID: 25555662
[TBL] [Abstract][Full Text] [Related]
26. Etonogestrel-releasing contraceptive implant in a patient using thalidomide for the treatment of erythema nodosum leprosum: a case report.
Ferreira-Filho ES; Bahamondes L; Duarte DC; Guimarães ALM; de Almeida PG; Soares-Júnior JM; Baracat EC; Sorpreso ICE
Gynecol Endocrinol; 2022 Jan; 38(1):90-93. PubMed ID: 34486922
[TBL] [Abstract][Full Text] [Related]
27. Immediate versus delayed insertion of an etonogestrel releasing implant at medical abortion-a randomized controlled equivalence trial.
Hognert H; Kopp Kallner H; Cameron S; Nyrelli C; Jawad I; Heller R; Aronsson A; Lindh I; Benson L; Gemzell-Danielsson K
Hum Reprod; 2016 Nov; 31(11):2484-2490. PubMed ID: 27664217
[TBL] [Abstract][Full Text] [Related]
28. Etonogestrel implant use in women primarily choosing a combined oral contraceptive pill: A proof-of-concept trial.
Chen MJ; Hsia JK; Creinin MD
Contraception; 2018 Jun; 97(6):533-537. PubMed ID: 29496473
[TBL] [Abstract][Full Text] [Related]
29. One-year follow-up of immediate postpartum contraceptive implant insertion in adolescents.
Barbieri MM; Dantas-Silva A; Caleffi LS; Morais SS; Juliato CRT; Bahamondes L; Surita FG
Eur J Contracept Reprod Health Care; 2023 Feb; 28(1):58-64. PubMed ID: 36287505
[TBL] [Abstract][Full Text] [Related]
30. Bleeding related to etonogestrel subdermal implant in a US population.
Casey PM; Long ME; Marnach ML; Bury JE
Contraception; 2011 May; 83(5):426-30. PubMed ID: 21477684
[TBL] [Abstract][Full Text] [Related]
31. Choice of the levonorgestrel intrauterine device, etonogestrel implant or depot medroxyprogesterone acetate for contraception after aspiration abortion.
Steinauer JE; Upadhyay UD; Sokoloff A; Harper CC; Diedrich JT; Drey EA
Contraception; 2015 Dec; 92(6):553-9. PubMed ID: 26093190
[TBL] [Abstract][Full Text] [Related]
32. Subdermal Contraceptive Implant Insertion Trends and Retention in Adolescents.
Tyson N; Lopez M; Merchant M; Postlethwaite D
J Pediatr Adolesc Gynecol; 2021 Jun; 34(3):348-354. PubMed ID: 33388444
[TBL] [Abstract][Full Text] [Related]
33. Influence of age on tolerability, safety and effectiveness of subdermal contraceptive implants.
López Del Cerro E; Serrano Diana C; Castillo Cañadas AM; González Mirasol E; García Santos F; Gómez García MT; González de Merlo G
J Obstet Gynaecol; 2018 Oct; 38(7):979-984. PubMed ID: 29553853
[TBL] [Abstract][Full Text] [Related]
34. Etonogestrel Implants in Adolescents: Experience, Satisfaction, and Continuation.
Obijuru L; Bumpus S; Auinger P; Baldwin CD
J Adolesc Health; 2016 Mar; 58(3):284-9. PubMed ID: 26903428
[TBL] [Abstract][Full Text] [Related]
35. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.
Hubacher D; Spector H; Monteith C; Chen PL; Hart C
Am J Obstet Gynecol; 2017 Feb; 216(2):101-109. PubMed ID: 27662799
[TBL] [Abstract][Full Text] [Related]
36. Postpartum weight loss in overweight and obese women using the etonogestrel subdermal implant: a pilot study.
Griffin L; Hammond C; Liu D; Rademaker AW; Kiley J
Contraception; 2017 Jun; 95(6):564-570. PubMed ID: 28238839
[TBL] [Abstract][Full Text] [Related]
37. The Etonogestrel Implant in Adolescents: Factors Associated With Removal for Bothersome Bleeding in the First Year After Insertion.
Green S; Sheeder J; Richards M
J Pediatr Adolesc Gynecol; 2021 Dec; 34(6):825-831. PubMed ID: 34089858
[TBL] [Abstract][Full Text] [Related]
38. Bioequivalence and x-ray visibility of a radiopaque etonogestrel implant versus a non-radiopaque implant: a 3-year, randomized, double-blind study.
Schnabel P; Merki-Feld GS; Malvy A; Duijkers I; Mommers E; van den Heuvel MW
Clin Drug Investig; 2012 Jun; 32(6):413-22. PubMed ID: 22540269
[TBL] [Abstract][Full Text] [Related]
39. Continuation of the etonogestrel implant in women undergoing immediate postabortion placement.
Madden T; Eisenberg DL; Zhao Q; Buckel C; Secura GM; Peipert JF
Obstet Gynecol; 2012 Nov; 120(5):1053-9. PubMed ID: 23090522
[TBL] [Abstract][Full Text] [Related]
40. Gene expression associated with unfavorable vaginal bleeding in women using the etonogestrel subdermal contraceptive implant: a prospective study.
Torelli FR; Rodrigues-Peres RM; Monteiro I; Lopes-Cendes I; Bahamondes L; Juliato CRT
Sci Rep; 2024 May; 14(1):11062. PubMed ID: 38745005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
